Canada Life’s Loxo Oncology, Inc LOXO Stock Holding History

Canada Life’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,568	Closed	-$347K	–	2763
2018 Q4	$347K	Hold	2,568	–	–	﹤0.01%	1792
2018 Q3	$439K	Hold	2,568	–	–	﹤0.01%	1773
2018 Q2	$446K	Sell	2,568 -390	-13%	-$58.6K	﹤0.01%	1773
2018 Q1	$342K	Hold	2,958	–	–	﹤0.01%	1821
2017 Q4	$248K	Hold	2,958	–	–	﹤0.01%	1910
2017 Q3	$275K	Buy	2,958 +1,958	+196%	+$152K	﹤0.01%	1869
2017 Q2	$80K	Hold	1,000	–	–	﹤0.01%	2180
2017 Q1	$42K	Hold	1,000	–	–	﹤0.01%	2352
2016 Q4	$32K	Hold	1,000	–	–	﹤0.01%	2424
2016 Q3	$26K	Hold	1,000	–	–	﹤0.01%	2449
2016 Q2	$23K	Buy	+1,000	New	+$24.9K	﹤0.01%	2454

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Canada Life's LOXO Position: Q1 2019 in Review

Canada Life sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 2,568 shares — an estimated $347K sold.

Canada Life first reported a position in LOXO in Q2 2016 and held it in 11 quarters. The position peaked at $446K in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Canada Life reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Canada Life sold 2,568 Loxo Oncology, Inc shares in Q1 2019, an estimated $347K.
Canada Life first reported a position in Loxo Oncology, Inc in Q2 2016 and held it in 11 quarters.
Canada Life's Loxo Oncology, Inc position peaked at $446K in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Canada Life's 13F filing for Q1 2019, filed 8 May 2019.